NCT05204277

Brief Summary

Background: Various treatment modalities are available to improve esthetics of fluorosed teeth based on its severity. Aim: evaluate the clinical performance of different minimal invasive treatment protocols on mild to moderate fluorosed teeth. Materials and Methods: Participants were randomly allocated in eight treatment protocols with twenty teeth (n=20) included in each protocol. (P1) Opalescence boost PF 40%. (P2) Opalustre. (P3) MI-Paste Plus. In (P4) teeth were treated with Opalustre + Opalescence boost PF 40%. In (P5) Opalescence boost PF 40% + MI-Paste Plus, while in (P6) Opalustre +MI-Paste Plus. Whereas (P7) Opalustre + Opalescence boost PF 40% + MI-Paste Plus. (P8) control. All teeth were evaluated for color change (∆E) immediately after treatment (T1), after 14 days (T2), after 3 months (T3) and after 6 months (T4). Statistical analysis: Two-way ANOVA was applied to test the interaction between different variables. ANOVA repeated measures were followed by Duncan multiple range tests (DMRTs) to compare between groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 8, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 6, 2020

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 24, 2020

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 10, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 24, 2022

Completed
Last Updated

January 24, 2022

Status Verified

January 1, 2022

Enrollment Period

8 months

First QC Date

January 10, 2022

Last Update Submit

January 10, 2022

Conditions

Keywords

Bleaching, microabrasion, CPP-ACFP, color change, ∆E

Outcome Measures

Primary Outcomes (1)

  • Color change (∆E)

    The color measurement was carried out 3 consecutive times with the same evaluator. At each time the obtained values were converted to the corresponding L, a and b values provided by the manufacturer and the mean of three measurements was taken. Color change was calculated from the formula ∆E=√((∆〖L)〗\^2+(∆〖a)〗\^2+〖(∆b)〗\^2 ) ,

    Six Months

Study Arms (8)

In-office bleaching

ACTIVE COMPARATOR

40% hydrogen peroxide in-office bleaching (Opalescence™ boost™ PF 40%, Ultradent Products, Inc., South Jordan, UT, USA)

Other: Opalescence™ boost™ PF 40%

microabrasion

ACTIVE COMPARATOR

6.6% hydrochloric acid and silicon carbide microparticles microabrasion paste (Opalustre™, Ultradent Products, Inc., South Jordan, UT, USA)

Other: Opalustre™

Remineralization

ACTIVE COMPARATOR

casein phosphopeptide amorphous calcium fluoride phosphate (CPP-ACFP) remineralizing tooth crème (MI-Paste Plus®, GC America Inc., USA).

Other: MI-Paste Plus®

Microabrasion + In-office bleaching

ACTIVE COMPARATOR

teeth were treated with enamel microabrasion followed by in-office bleaching.

Other: Opalescence™ boost™ PF 40%Other: Opalustre™

In-office bleaching + Remineralization

ACTIVE COMPARATOR

In-office bleaching was applied followed by MI-Paste Plus®

Other: Opalescence™ boost™ PF 40%Other: MI-Paste Plus®

Microabrasion + Remineralization

ACTIVE COMPARATOR

microabrasion was applied followed by MI-Paste Plus®

Other: Opalustre™Other: MI-Paste Plus®

Microabrasion + In-office bleaching + Remineralization

ACTIVE COMPARATOR

teeth were treated with microabrasion followed by inoffice bleaching and lastly MI-Paste Plus®

Other: Opalescence™ boost™ PF 40%Other: Opalustre™Other: MI-Paste Plus®

Control

NO INTERVENTION

no treatment (control)

Interventions

40% hydrogen peroxide in-office bleaching

In-office bleachingIn-office bleaching + RemineralizationMicroabrasion + In-office bleachingMicroabrasion + In-office bleaching + Remineralization

6.6% hydrochloric acid and silicon carbide microparticles microabrasion paste

Microabrasion + In-office bleachingMicroabrasion + In-office bleaching + RemineralizationMicroabrasion + Remineralizationmicroabrasion

casein phosphopeptide amorphous calcium fluoride phosphate (CPP-ACFP) remineralizing tooth crème

In-office bleaching + RemineralizationMicroabrasion + In-office bleaching + RemineralizationMicroabrasion + RemineralizationRemineralization

Eligibility Criteria

Age20 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Each participant had at least 8 teeth with mild to moderate dental fluorosis score 1-4 according to Thylstrup and Fejerskov index.
  • Participants of age range 20-35 years old
  • Good oral and general health
  • Had no caries or restorations on the teeth to be treated
  • Ability to return for periodic recalls

You may not qualify if:

  • Hypersensitive teeth
  • Any fixed orthodontic appliance
  • Current or previous use of bleaching agents
  • A history of allergies to tooth whitening product
  • Smoking habits
  • Pregnant or lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of dentistry, Suez canal university

Ismailia, Egypt

Location

MeSH Terms

Conditions

Fluorosis, Dental

Interventions

opalustre

Condition Hierarchy (Ancestors)

Dental Enamel HypomineralizationDevelopmental Defects of EnamelTooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Masking was ensured as the baseline and follow-ups data were stored on a computer with a unique ID and the investigators were not disclosed about the participants' treatment protocol. Blinding of the participants was guaranteed as they didn't know each other, or the treatments received in other protocols
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Mostafa Nasser Abdelmoniem Youssef

Study Record Dates

First Submitted

January 10, 2022

First Posted

January 24, 2022

Study Start

September 8, 2019

Primary Completion

May 6, 2020

Study Completion

December 24, 2020

Last Updated

January 24, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations